Latest filing published 05 Jun 2026 for DENTSPLY SIRONA Inc..
Based on 19 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
For Gregory T. Lucier, purchases dominate: 35 against 7 sales, which is 83% of open-market trades. They represent EUR 7.1 million, with a median of EUR 182,862; the largest are dated May 23, 2019 (EUR 479,232, at Dentsply Sirona Inc.), July 16, 2020 (EUR 438,895, at Berkeley Lights, Inc.) and March 4, 2021 (EUR 438,773, at Dentsply Sirona Inc.). The sales weigh EUR 6.3 million, with a median of EUR 786,676; the largest, EUR 1,821,187, is from July 30, 2020 at Catalent, Inc.
The record holds 133 filings between February 3, 2016 and June 5, 2026, under the title "Director" at seven companies, among them Dentsply Sirona Inc. (54), Nuvasive Inc (25), Catalent, Inc. (19), Maravai Lifesciences Holdings, Inc. (12) and Invuity, Inc. (11). The record also contains 65 grants, 11 option exercises and 15 filings of another type.
In the last 12 months, 11 filings were published, 6 of them purchases and 1 a sale. For 19 purchases with a stored 90-day result, the median is negative (6.2%) and 32% of results are positive (stored past results, not a forecast).
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 133 declarations